Fat10: Activated by UBA6 and functioning in protein degradation

Subcellular Biochemistry

Volumn 54, Issue , 2010, Pages 238-246

  Pelzer, Christiane ^a   Groettrup, Marcus ^b  

^a University of Constance ^*

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EUKARYOTA;

PROTEIN BINDING; UBIQUITIN;

ENZYME ACTIVATION; HUMAN; METABOLISM; PROTEIN DEGRADATION;

ENZYME ACTIVATION; HUMANS; PROTEIN BINDING; PROTEOLYSIS; UBIQUITIN; UBIQUITINS;

EID: 80052764047     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6676-6_19     Document Type: Article

References (73)

1. Ciechanover A, Heller H, Katz-Etzion R et al. Activation of the heat-stable polypeptide of the ATP-dependent proteolytic system. Proc Natl Acad Sci USA 1981; 78:761-5.
2. Haas AL, Warms JV, Hershko A et al. Ubiquitin-activating enzyme. Mechanism and role in protein-ubiquitin conjugation. J Biol Chem 1982; 257:2543-8.
3. Hershko A, Heller H, Elias S et al. Components ofubiquitin-protein ligase system. Resolution, ffinity purification and role in protein breakdown. J Biol Chem 1983; 258:8206-14.
4. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425-79.
5. Ciechanover A. The ubiquitin-proteasome pathway: onprotein death andcell life. EMBO J 1998; 17:7151-60.
6. Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J 2005; 24:3353-9.
7. Hochstrasser M. Evolution and function of ubiquitin-like protein-conjugation systems. Nat Cell Biol 2000; 2:E153-7.
8. Hurley JH, Lee S, Prag G. Ubiquitin-binding domains. Biochem J 2006; 399:361-72.
9. Kerscher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Ann Rev Cell Dev Biol 2006; 22:159-80.
10. Pelzer C, Kassner I, Matentzoglu K et al. UBE1L2, a novel E1 enzyme specific for ubiquitin. J Biol Chem 2007;282:23010-4.
11. Jin J, Li X, Gygi SP et al. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature2007; 447:1135-8.
12. Chiu YH, Sun Q, Chen ZJ. E1-L2 activates both ubiquitin and FAT10. Mol Cell 2007; 27:1014-23.
13. Lehmann C, Begley TP, Ealick SE. Structure of the Escherichia coli ThiS-ThiF complex, a key component ofthe sulfurtransfersysteminthiaminbiosynthesis. Biochemistry2006; 45:11-9.
14. Lake MW, Wuebbens MM, Rajagopalan KV et al. Mechanism of ubiquitin activation revealed by the structure ofabacterial MoeB-MoaD complex. Nature 2001; 414:325-9.
15. Huang DT, Walden H, Duda D et al. Ubiquitin-like protein activation. Oncogene 2004; 23:1958-71.
16. Groettrup M, Pelzer C, Schmidtke G et al. Activating the ubiquitin family: UBA6 challenges the field. Trends Biochem Sci 2008; 33:230-7.
17. Dye BT, Schulman BA. Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins. Annu Rev Biophys Biomol Struct 2007; 36:131-50.
18. Walden H, Podgorski MS, Huang DT et al. The structure ofthe APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activationby an E1. Mol Cell 2003; 12:1427-37.
19. Walden H, Podgorski MS, Schulman BA. Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8. Nature 2003; 422:330-4.
20. Lois LM, Lima CD. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1. EMBO J 2005; 24:439-51.
21. Lee I, Schindelin H. Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes. Cell 2008; 134:268-78.
22. Johnson ES, Schwienhorst I, Dohmen RJ et al. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J 1997; 16:5509-19.
23. Liakopoulos D, Doenges G, Matuschewski K et al. A novel protein modification pathway related to the ubiquitin system. EMBO J 1998; 17:2208-14.
24. Szczepanowski RH, Filipek R, Bochtler M. Crystal structure of a fragment of mouse ubiquitin-activating enzyme. J Biol Chem 2005;280:22006-11.
25. Huang DT, Paydar A, Zhuang M et al. Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8's E1. Mol Cell 2005; 17:341-50.
26. Huang DT, Hunt HW, Zhuang M et al. Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity. Nature 2007; 445:394-8.
27. Komatsu M, Chiba T, Tatsumi K et al. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J 2004; 23:1977-86.
28. Schmitz J, Chowdhury MM, Hanzelmann P et al. The sulfurtransferase activity of Uba4 presents a link between ubiquitin-like protein conjugation and activation of sulfur carrier proteins. Biochemistry 2008; 47:6479-89.
29. Tanida I, Tanida-Miyake E, Ueno T et al. The human homolog of Saccharomyces cerevisiae Apg7p is a Protein-activating enzyme for multiple substrates including human Apg12p, GATE-16, ABARAP and MAP-LC3. J Biol Chem 2001; 276:1701-6.
30. Komatsu M, Tanida I, Ueno T et al. The C-terminal region of an Apg7p/Cvt2p is required for homodimerization and is essential for its E1 activity and E1-E2 complex formation. J Biol Chem 2001; 276:9846-54.
31. Haas AL, Warms JV, Rose IA. Ubiquitin adenylate: structure androle inubiquitin activation. Biochemistry 1983; 22:4388-94.
32. Haas AL, Rose IA. The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis. J Biol Chem 1982;257:10329-37.
33. Ciechanover A, Elias S, Heller H et al. "Covalent affinity" purification of ubiquitin-activating enzyme. J Biol Chem 1982; 257:2537-42
34. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001; 70:503-33.
35. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2001; 2:211-6.
36. Ichimura Y, Kirisako T, Takao T et al. A ubiquitin-like system mediates protein lipidation. Nature 2000; 408:488-92.
37. Ohsumi Y, Mizushima N. Two ubiquitin-like conjugation systems essential for autophagy. Semin Cell Dev Biol2004; 15:231-6.
38. Gong L, Li B, Millas S et al. Molecular cloning and characterization of human AOS1 andUBA2, components of the sentrin-activating enzyme complex. FEBS Lett 1999; 448:185-9.
39. Desterro JM, Rodriguez MS, Kemp GD et al. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J Biol Chem 1999; 274:10618-24.
40. Zheng M, Gu X, Zheng, Detal. UBE1DC1, an ubiquitin-activating enzyme, activates two differentubiquitin-like proteins. J Cell Biochem 2008; 104:2324-34.
41. Canaan A, Yu X, Booth CJ et al. FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol 2006; 26:5180-9.
42. Yuan W, Krug RM. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J2001; 20:362-71.
43. Hatfield PM, Gosink MM, Carpenter TB et al. The ubiquitin-activating enzyme (E1) gene family in Arabidopsis thaliana. PlantJ 1997; 11:213-26.
44. Hatfield PM, Vierstra RD. Multiple forms of ubiquitin-activating enzyme E1 from wheat. Identification ofanessentialcysteinebyinvitromutagenesis. JBiolChem 1992; 267:14799-803.
45. Gu X, Zhao F, Zheng M et al. Cloning and characterization of a gene encoding the human putative ubiquitinconjugating enzyme E2Z (UBE2Z). Mol Biol Rep 2007; 34:183-8.
46. Fan W, Cai W, Parimoo S et al. Identification of seven new human MHC class I region genes around theHLA-F locus. Immunogenetics 1996; 44:97-103.
47. Liu YC, Pan J, Zhang C et al. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to thespindle assembly checkpoint protein MAD2. Proc Natl Acad Sci USA 1999; 96:4313-8.
48. Raasi S, Schmidtke G, Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and inducesapoptosis. J Biol Chem 2001; 276:35334-43.
49. Narasimhan J, Wang M, Fu Z et al. Crystal structure of the interferon-induced ubiquitin-like protein ISG15.J Biol Chem 2005; 280:27356-65.
50. Raasi S, Schmidtke G, de Giuli R et al. A ubiquitin-like protein which is synergistically inducible byinterferon-gamma and tumor necrosis factor-alpha. Eur J Immunol 1999; 29:4030-6.
51. Bates EFM, Ravel O, Dieu MC et al. Identification and analysis of a novel member of the ubiquitin familyexpressed in dendritic cells and mature B-cells. Eur J Immunol 1997; 27:2471-7.
52. Lukasiak S, Schiller C, Oehlschlaeger P et al. Proinflammatory cytokines cause FAT10 upregulation in cancersofliver and colon. Oncogene 2008; 27:6068-74.
53. Lee CG, Ren J, Cheong IS et al. Expression ofthe FAT10 gene is highly upregulated inhepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003; 22:2592-603.
54. Xiong W, Wang X, Liu XY et al. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2003; 35:1053-60.
55. Ocklenburg F, Moharregh-Khiabani D, Geffers R et al. UBD, a downstream element of FOXP3, allows the identification ofLGALS3, a new marker ofhuman regulatory T-cells. Lab Invest 2006; 86:724-37.
56. Ebstein F, Lange N, Urban S et al. Maturation ofhuman dendritic cells is accompanied by functional remodeling of the ubiquitin-proteasome system. Int J Biochem Cell Biol 2008.
57. Ross MJ, Wosnitzer MS, Ross MD et al. Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J Am Soc Nephrol 2006; 17:996-1004.
58. Coyle B, Freathy C, Gant TW et al. Characterization of the transforming growth factor-beta 1-induced apoptotic transcriptome in FaO hepatoma cells. J Biol Chem 2003; 278:5920-8.
59. Ren J, Kan A, Leong SH et al. FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem 2006;281:11413-21.
60. FitzPatrick DR, Ramsay J, McGill NI et al. Transcriptome analysis ofhuman autosomal trisomy. Hum Mol Genet2002; 11:3249-56.
61. Hipp MS, Kalveram B, Raasi S et al. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol. 2005; 25:3483-91.
62. Oliva J, Bardag-Gorce F, French BA et al. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mousemodeloftumorigenesis. ExpMolPathol2008; 84:102-12.
63. Zhang DW, Jeang KT, Lee CG. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 2006; 25:2318-27.
64. Dokmanovic M, Chang BD, Fang J et al. Retinoid-induced growth arrest ofbreast carcinoma cells involves co-activation of multiple growth-inhibitory genes. Cancer Biol Ther 2002; 1:24-7.
65. Hipp MS, Raasi S, Groettrup M et al. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J Biol Chem 2004; 279:16503-10.
66. Kamitani T, Kito K, Fukuda-Kamitani T et al. Targeting of NEDD8 and its conjugates for proteasomal degradationbyNUB1.J BiolChem2001; 276:46655-60.
67. Schmidtke G, Kalveram B, Weber E et al. The UBA domains of NUB1L are required for binding but not for accelerated degradation ofthe ubiquitin-like modifier FAT10. J Biol Chem 2006; 281:20045-54.
68. Schauber C, Chen L, Tongaonkar P et al. Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature 1998;391:715-8.
69. Raasi S, Varadan R, Fushman D et al. Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nat Struct Mol Biol 2005; 12:708-14.
70. Schmidtke G, Kalveram B, Groettrup M. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L. FEBS Lett 2009; 583:591-4.
71. Kalveram B, Schmidtke G, Groettrup M. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J Cell Sci 2008; 121:4079-88.
72. Iwata A, Riley BE, Johnston JA et al. HDAC6 and microtubules are required for autophagic degradation of aggregatedhuntingtin. J Biol Chem 2005; 280:40282-92.
73. Pandey UB, Nie Z, Batlevi Y et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007; 447:859-63.